Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Nabi-NicVAX attenuates nicotine dependence in rats

March 1, 2000

Study disproves earlier reports of serious treatment-related side effect of deferiprone

Feb. 24, 2000

Elan/Endorex joint venture to develop iron-chelating products with Schein

Feb. 24, 2000

Small patient study indicates potential of baclofen in treating alcoholism

Feb. 22, 2000

Ecopipam is able to attenuate the mood-altering and other effects of acute cocaine

Feb. 10, 2000

Antizol granted conditional priority review by Canadian authorities

Feb. 8, 2000

Piperidine, pyrrolidine and pyrroline derivatives selectively affect 5-HT function

Feb. 2, 2000

New series from Lilly affecting serotonergic pathways

Feb. 1, 2000

Naltriben: potential new pharmacotherapeutic for reducing alcohol intake

Jan. 17, 2000

Pharmacological profile of SR-141716A, a selective CB1 antagonist, further characterized

Dec. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...